0001140361-11-014431.txt : 20110304
0001140361-11-014431.hdr.sgml : 20110304
20110304165148
ACCESSION NUMBER: 0001140361-11-014431
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110302
FILED AS OF DATE: 20110304
DATE AS OF CHANGE: 20110304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Malik Rajiv
CENTRAL INDEX KEY: 0001388111
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09114
FILM NUMBER: 11665344
MAIL ADDRESS:
STREET 1: 1500 CORPORATE DRIVE, SUITE 400
CITY: CANONSBURG
STATE: PA
ZIP: 15317
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYLAN INC.
CENTRAL INDEX KEY: 0000069499
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 251211621
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1500 CORPORATE DRIVE
STREET 2: SUITE 400
CITY: CANONSBURG
STATE: PA
ZIP: 15317
BUSINESS PHONE: 724-514-1800
MAIL ADDRESS:
STREET 1: 1500 CORPORATE DRIVE
STREET 2: SUITE 400
CITY: CANONSBURG
STATE: PA
ZIP: 15317
FORMER COMPANY:
FORMER CONFORMED NAME: MYLAN LABORATORIES INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: FRM CORP
DATE OF NAME CHANGE: 19711003
4
1
doc1.xml
FORM 4
X0303
4
2011-03-02
0
0000069499
MYLAN INC.
MYL
0001388111
Malik Rajiv
1500 CORPORATE DRIVE
CANONSBURG
PA
15317
0
1
0
0
EVP & Chief Operating Officer
Common Stock
2011-03-03
4
M
0
6409
0
A
96691
D
Common Stock
2011-03-04
4
S
0
2065
22.95
D
94626
D
Employee Stock Option - Right to Buy
22.66
2011-03-02
4
A
0
80264
0
A
2021-03-02
Common Stock
80264
80264
D
Restricted Stock Units
0
2011-03-02
4
A
0
28961
0
A
Common Stock
28961
28961
D
Restricted Stock Units
0
2011-03-03
4
M
0
6409
0
A
Common Stock
6409
0
D
Note that the amount of securities beneficially owned has been adjusted to reflect the current transaction as well as a reduction of 10,000 shares to correct an inadvertent overstatement of shares owned reported on a Form 4 filing on February 2, 2010. Each Form 4 filed for this reporting person during the period beginning on February 2, 2010 through July 29, 2010 incorrectly overstated by 10,000 shares the amount of securities beneficially owned following the transaction(s) reported on such Form 4.
Represents the shares sold to cover the tax liability associated with the vesting of a portion of the restricted stock awards (RSUs) granted on March 3, 2010.
These options vest in three equal annual installments beginning on March 2, 2012 and expire March 2, 2021.
Each RSU represents the right to receive one share of Mylan Inc. common stock. The RSUs vest in three equal annual installments beginning on March 2, 2012.
Each RSU represents the right to receive one share of Mylan Inc. common stock. The remainder of this award will vest equally on March 3, 2012 and 2013.
/s/ Rajiv Malik
2011-03-04